FGFR2 overexpression and compromised survival in diffuse-type gastric cancer in a large central European cohort. Schrumpf T, Behrens HM, Haag J, Kruger S, et al. PLoS One 2022;17:e0264011.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Schrumpf T, Behrens HM, Haag J, Kruger S, et al. FGFR2 overexpression and compromised survival in diffuse-type gastric cancer in a large central European cohort. PLoS One 2022;17:e0264011.
PMID: 35167603